BIO-TECHNE Corp Quarterly Liabilities, Current in USD from Q2 2010 to Q1 2025

Taxonomy & unit: us-gaap: USD
Description: Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Summary: BIO-TECHNE Corp quarterly Liabilities, Current history and growth rate from Q2 2010 to Q1 2025.
BIO-TECHNE Corp Liabilities, Current for the quarter ending March 31, 2025 was $169M, a 12.9% increase year-over-year.

Liabilities, Current, Quarterly (USD)

Liabilities, Current, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q1 2025	$169M	+$19.4M	+12.9%	Mar 31, 2025	10-Q	2025-05-08
Q4 2024	$161M	+$26M	+19.2%	Dec 31, 2024	10-Q	2025-02-06
Q3 2024	$142M	+$14.4M	+11.3%	Sep 30, 2024	10-Q	2024-11-05
Q2 2024	$159M	+$30.9M	+24%	Jun 30, 2024	10-Q	2025-05-08
Q1 2024	$150M	+$8.66M	+6.13%	Mar 31, 2024	10-Q	2024-05-06
Q4 2023	$135M	+$6.84M	+5.32%	Dec 31, 2023	10-Q	2024-02-07
Q3 2023	$128M	-$9.88M	-7.18%	Sep 30, 2023	10-Q	2023-11-07
Q2 2023	$129M	-$47.5M	-27%	Jun 30, 2023	10-K	2024-08-22
Q1 2023	$141M	-$25.7M	-15.4%	Mar 31, 2023	10-Q	2023-05-08
Q4 2022	$128M	-$26.4M	-17.1%	Dec 31, 2022	10-Q	2023-02-07
Q3 2022	$138M	+$3.64M	+2.71%	Sep 30, 2022	10-Q	2022-11-07
Q2 2022	$176M	+$23.7M	+15.6%	Jun 30, 2022	10-K	2023-08-23
Q1 2022	$167M	+$29.2M	+21.2%	Mar 31, 2022	10-Q	2022-05-09
Q4 2021	$155M	+$37.2M	+31.7%	Dec 31, 2021	10-Q	2022-02-07
Q3 2021	$134M	+$28.6M	+27.1%	Sep 30, 2021	10-Q	2021-11-08
Q2 2021	$152M	+$45.6M	+42.8%	Jun 30, 2021	10-K	2022-08-24
Q1 2021	$138M	+$32.7M	+31.1%	Mar 31, 2021	10-Q	2021-05-07
Q4 2020	$118M	+$12.6M	+12%	Dec 31, 2020	10-Q	2021-02-08
Q3 2020	$105M	+$17.2M	+19.4%	Sep 30, 2020	10-Q	2020-11-09
Q2 2020	$107M	+$4.68M	+4.59%	Jun 30, 2020	10-K	2021-08-25
Q1 2020	$105M	+$6.94M	+7.08%	Mar 31, 2020	10-Q	2020-05-11
Q4 2019	$105M	+$17.5M	+20%	Dec 31, 2019	10-Q	2020-02-06
Q3 2019	$88.3M	+$4.83M	+5.78%	Sep 30, 2019	10-Q	2019-11-06
Q2 2019	$102M	+$22.5M	+28.3%	Jun 30, 2019	10-K	2020-08-26
Q1 2019	$98M	+$27.2M	+38.3%	Mar 31, 2019	10-Q	2019-05-07
Q4 2018	$87.4M	-$24.2M	-21.7%	Dec 31, 2018	10-Q	2019-02-07
Q3 2018	$83.4M	-$23.6M	-22%	Sep 30, 2018	10-Q	2018-11-07
Q2 2018	$79.5M	-$56M	-41.3%	Jun 30, 2018	10-K/A	2019-11-06
Q1 2018	$70.9M	-$71.3M	-50.1%	Mar 31, 2018	10-Q	2018-05-09
Q4 2017	$112M	-$8.65M	-7.19%	Dec 31, 2017	10-Q	2018-02-08
Q3 2017	$107M	+$15K	+0.01%	Sep 30, 2017	10-Q	2017-11-09
Q2 2017	$136M	+$81.4M	+150%	Jun 30, 2017	10-K	2018-08-27
Q1 2017	$142M	+$95.6M	+205%	Mar 31, 2017	10-Q	2017-05-10
Q4 2016	$120M	+$84.5M	+236%	Dec 31, 2016	10-Q	2017-02-09
Q3 2016	$107M	+$62M	+138%	Sep 30, 2016	10-Q	2016-11-09
Q2 2016	$54.1M	+$14.4M	+36.2%	Jun 30, 2016	10-K	2017-09-07
Q1 2016	$46.6M	+$8.1M	+21%	Mar 31, 2016	10-Q	2016-05-10
Q4 2015	$35.8M	-$8.45M	-19.1%	Dec 31, 2015	10-Q	2016-02-09
Q3 2015	$45M	+$4.42M	+10.9%	Sep 30, 2015	10-Q	2015-11-09
Q2 2015	$39.8M	+$13.4M	+50.7%	Jun 30, 2015	10-K	2016-08-29
Q1 2015	$38.5M	+$14.1M	+58.1%	Mar 31, 2015	10-Q	2015-05-11
Q4 2014	$44.3M	+$22.2M	+100%	Dec 31, 2014	10-Q	2015-02-09
Q3 2014	$40.6M	+$20.3M	+100%	Sep 30, 2014	10-Q	2014-11-10
Q2 2014	$26.4M	-$5.69M	-17.7%	Jun 30, 2014	10-K	2015-08-31
Q1 2014	$24.4M	-$8.12M	-25%	Mar 31, 2014	10-Q	2014-05-12
Q4 2013	$22.1M	+$841K	+3.95%	Dec 31, 2013	10-Q	2014-02-04
Q3 2013	$20.3M	-$2.63M	-11.5%	Sep 30, 2013	10-Q	2013-11-12
Q2 2013	$32.1M	-$3.67M	-10.3%	Jun 30, 2013	10-K	2014-08-29
Q1 2013	$32.5M	+$1.76M	+5.73%	Mar 31, 2013	10-Q	2013-05-10
Q4 2012	$21.3M	+$7.15M	+50.6%	Dec 31, 2012	10-Q	2013-02-11

Previous1 2Next

Showing 1 to 50 of 60 entries

* An asterisk sign (*) next to the value indicates that the value is likely invalid.